These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11130199)

  • 1. A validation study comparing accelerator MS and liquid scintillation counting for analysis of 14C-labelled drugs in plasma, urine and faecal extracts.
    Garner RC; Barker J; Flavell C; Garner JV; Whattam M; Young GC; Cussans N; Jezequel S; Leong D
    J Pharm Biomed Anal; 2000 Dec; 24(2):197-209. PubMed ID: 11130199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical performance of accelerator mass spectrometry and liquid scintillation counting for detection of 14C-labeled atrazine metabolites in human urine.
    Gilman SD; Gee SJ; Hammock BD; Vogel JS; Haack K; Buchholz BA; Freeman SP; Wester RC; Hui X; Maibach HI
    Anal Chem; 1998 Aug; 70(16):3463-9. PubMed ID: 9726169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerator mass spectrometry in pharmaceutical research and development--a new ultrasensitive analytical method for isotope measurement.
    Garner RC
    Curr Drug Metab; 2000 Sep; 1(2):205-13. PubMed ID: 11465084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of accelerator mass spectrometry in a human mass balance and pharmacokinetic study-experience with 14C-labeled (R)-6-[amino(4- chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1- methyl-2(1H)-quinolinone (R115777), a farnesyl transferase inhibitor.
    Garner RC; Goris I; Laenen AA; Vanhoutte E; Meuldermans W; Gregory S; Garner JV; Leong D; Whattam M; Calam A; Snel CA
    Drug Metab Dispos; 2002 Jul; 30(7):823-30. PubMed ID: 12065441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of low background liquid scintillation counter for non-clinical ADME studies.
    Onishi A; Kogame A; Tagawa Y; Kondo T; Asahi S
    Xenobiotica; 2013 Jun; 43(6):520-6. PubMed ID: 23256624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting.
    Garner RC; Garner JV; Gregory S; Whattam M; Calam A; Leong D
    J Pharm Sci; 2002 Jan; 91(1):32-40. PubMed ID: 11782895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attomole detection of 3H in biological samples using accelerator mass spectrometry: application in low-dose, dual-isotope tracer studies in conjunction with 14C accelerator mass spectrometry.
    Dingley KH; Roberts ML; Velsko CA; Turteltaub KW
    Chem Res Toxicol; 1998 Oct; 11(10):1217-22. PubMed ID: 9778319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation profiling of [(14)C]ixabepilone in human plasma, urine and feces samples using accelerator mass spectrometry (AMS).
    Cömezoğlu SN; Ly VT; Zhang D; Humphreys WG; Bonacorsi SJ; Everett DW; Cohen MB; Gan J; Beumer JH; Beijnen JH; Schellens HM; Lappin G
    Drug Metab Pharmacokinet; 2009; 24(6):511-22. PubMed ID: 20045986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerator mass spectrometry (AMS): recent experience of its use in a clinical study and the potential future of the technique.
    Young G; Ellis W; Ayrton J; Hussey E; Adamkiewicz B
    Xenobiotica; 2001; 31(8-9):619-32. PubMed ID: 11569529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of 96-well Scintiplates to facilitate definitive metabolism studies for drug candidates.
    Nedderman AN; Savage ME; White KL; Walker DK
    J Pharm Biomed Anal; 2004 Feb; 34(3):607-17. PubMed ID: 15127817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of liquid chromatography-accelerator mass spectrometry (LC-AMS) to evaluate the metabolic profiles of a drug candidate in human urine and plasma.
    Prakash C; Shaffer CL; Tremaine LM; Liberman RG; Skipper PL; Flarakos J; Tannenbaum SR
    Drug Metab Lett; 2007 Aug; 1(3):226-31. PubMed ID: 19356047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerator mass spectrometry analysis of background (14)C-concentrations in human blood: aiming at reference data for further microdosing studies.
    Minamimoto R; Hamabe Y; Miyaoka T; Hara T; Yoshida K; Oka T; Inoue T
    Ann Nucl Med; 2008 Dec; 22(10):883-9. PubMed ID: 19142707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A microplate solid scintillation counter as a radioactivity detector for high performance liquid chromatography in drug metabolism: validation and applications.
    Bruin GJ; Waldmeier F; Boernsen KO; Pfaar U; Gross G; Zollinger M
    J Chromatogr A; 2006 Nov; 1133(1-2):184-94. PubMed ID: 16970958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the tissue distribution and excretion by accelerator mass spectrometry of the nonadecapeptide 14C-Moli1901 in beagle dogs after intratracheal instillation.
    Rickert DE; Dingley K; Ubick E; Dix KJ; Molina L
    Chem Biol Interact; 2005 Jun; 155(1-2):55-61. PubMed ID: 15893299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The estimation of low levels of 14C in biological samples by alkaline extraction and liquid scintillation counting.
    Huskisson NS; Ward PF
    Int J Appl Radiat Isot; 1982 Apr; 33(4):241-8. PubMed ID: 7085125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on DNA adduction with heterocyclic amines by accelerator mass spectrometry: a new technique for tracing isotope-labelled DNA adduction.
    Turteltaub KW; Vogel JS; Frantz CE; Fultz E
    IARC Sci Publ; 1993; (124):293-301. PubMed ID: 8225498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of simultaneous determination of 3H, 14C, and 22Na by liquid scintillation counting to the measurement of cellular ion-transport.
    Miyazawa Y; Sakai N; Murakami N; Konishi T
    Anal Biochem; 1991 Oct; 198(1):194-9. PubMed ID: 1789425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of low level radioactive metabolites in biological fluids using high-performance liquid chromatography with microplate scintillation counting: method validation and application.
    Zhu M; Zhao W; Vazquez N; Mitroka JG
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):233-45. PubMed ID: 15899570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers.
    Blight AR; Henney HR
    Clin Ther; 2009 Feb; 31(2):328-35. PubMed ID: 19302905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cAMS for
    Lozac'h F; Fahrni S; Maria D; Welte C; Bourquin J; Synal HA; Pearson D; Walles M; Camenisch G
    Bioanalysis; 2018 Mar; 10(5):321-339. PubMed ID: 29451392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.